Profitelligence provides financial data and analytics for informational purposes only. Nothing on this platform constitutes investment advice, a recommendation, or an offer to buy or sell any securities. Past performance does not guarantee future results. Always do your own research and consult a licensed financial advisor before making investment decisions.
By continuing, you acknowledge that you have read and agree to our Terms of Service and Privacy Policy.
You're browsing as a guest. Some features like watchlists and alerts require a free account.

Intuitive Surgical, Inc.
| Time | Ticker | Type | Event | Qty | Price | Value |
|---|---|---|---|---|---|---|
| 07/27 | ISRG | 8-K | Intuitive Surgical Updates Corporate Governance with Bylaw Amendments | — | — | — |
| 07/16 | ISRG | 8-K | Intuitive Surgical Reports Strong Q2 2026 Financial Results | — | — | — |
| 05/28 | ISRG | 8-K | Intuitive Surgical Appoints New Chief Commercial and Marketing Officer | — | — | — |
| 05/04 | ISRG | 8-K | Intuitive Surgical Approves Amended Incentive Award Plan and Increases Stock Repurchase Program | — | — | — |
| 04/21 | ISRG | 8-K | Intuitive Surgical Reports Strong Q1 2026 Financial Results and Outlook | — | — | — |
| 03/02 | ISRG | 8-K | Intuitive Surgical Completes Acquisition of da Vinci and Ion Distribution Business in Europe | — | — | — |
| 01/22 | ISRG | 8-K | Intuitive Surgical Reports Strong Q4 2025 Financial Results | — | — | — |
| 01/14 | ISRG | 8-K | Intuitive Surgical Announces Strong 2025 Financial Performance | — | — | — |
| 12/18/25 | ISRG | 8-K | Intuitive Surgical's Chief Digital Officer Transitions to New Role | — | — | — |
| 10/21/25 | ISRG | 8-K | Intuitive Surgical Announces Quarterly Financial Results | — | — | — |
| 07/22/25 | ISRG | 8-K | Intuitive Surgical Announces Financial Results for Q2 2025 | — | — | — |
| 05/15/25 | ISRG | 8-K | Intuitive Surgical Announces CEO Transition with Dave Rosa Promotion | — | — | — |
| 05/05/25 | ISRG | 8-K | Intuitive Surgical Announces Approval of Amended Incentive Plan and Stock Repurchase Program | — | — | — |
| 04/22/25 | ISRG | 8-K | Intuitive Surgical Announces Q1 2025 Financial Results | — | — | — |
| 01/23/25 | ISRG | 8-K | Intuitive Surgical to Acquire da Vinci Distribution in Southern Europe | — | — | — |
| 01/15/25 | ISRG | 8-K | Intuitive Surgical Reports Preliminary Q4 and Full Year 2024 Financial Results | — | — | — |
| 01/06/25 | ISRG | 8-K | Intuitive Surgical Promotes Key Executives | — | — | — |
| 10/17/24 | ISRG | 8-K | Intuitive Surgical Announces Financial Results for Q3 2024 | — | — | — |
| 07/25/24 | ISRG | 8-K | Intuitive Appoints President to Board of Directors | — | — | — |
| 07/18/24 | ISRG | 8-K | Intuitive Surgical Reports Strong Q2 2024 Financial Results | — | — | — |
| 04/30/24 | ISRG | 8-K | Intuitive Surgical Announces New Board Appointments and Proposal Outcomes | — | — | — |
| 04/18/24 | ISRG | 8-K | Intuitive Surgical Announces Quarterly Financial Results | — | — | — |
| 03/14/24 | ISRG | 8-K | Intuitive Surgical Announces FDA Clearance for da Vinci 5 | — | — | — |
| 01/23/24 | ISRG | 8-K | Intuitive Surgical Announces Q4 2023 Financial Results | — | — | — |
| 01/09/24 | ISRG | 8-K | Intuitive Surgical Reports Strong Preliminary 2023 Results | — | — | — |
Intuitive Surgical, Inc. (ISRG): 25 8-K filings summarized, the most recent on Jul 27, 2026.
On July 23, 2026, Intuitive Surgical, Inc. amended its Amended and Restated Bylaws to enhance corporate governance, including changes to shareholder voting rules, proxy solicitation procedures, and disclosure requirements for shareholder nominations and proposals. These amendments aim to streamline the nomination…
Intuitive Surgical Updates Corporate Governance with Bylaw AmendmentsIntuitive Surgical, Inc. announced its financial results for the quarter ended June 30, 2026, reporting a 19% increase in revenue to $2.89 billion. The company saw a 16% growth in worldwide procedures, with da Vinci procedures up 15% and Ion procedures up 36%. Net income attributable to Intuitive Surgical, Inc. was…
Intuitive Surgical Reports Strong Q2 2026 Financial ResultsIntuitive Surgical, Inc. announced on May 28, 2026, that Taylor Patton will succeed Henry L. Charlton as the Company's Chief Commercial and Marketing Officer, effective July 1, 2026. Charlton will transition to the role of Senior Vice President of Global Business Operations. Patton, with nearly two decades of…
Intuitive Surgical Appoints New Chief Commercial and Marketing OfficerIntuitive Surgical, Inc. announced that its stockholders approved the amendment and restatement of the Company's Amended and Restated 2010 Incentive Award Plan at the Annual Meeting held on April 30, 2026. The amendment increases the number of shares reserved for issuance under the plan and extends its term.…
Intuitive Surgical Approves Amended Incentive Award Plan and Increases Stock Repurchase ProgramIntuitive Surgical, Inc. announced its financial results for the first quarter of 2026, reporting a 23% increase in revenue to $2.77 billion. The company saw growth in worldwide procedures, with da Vinci procedures up 16% and Ion procedures up 39%. The installed base of da Vinci systems grew 12% to 11,395 systems, and…
Intuitive Surgical Reports Strong Q1 2026 Financial Results and Outlook